Akt associates with nuclear factor κB and plays an important role in chemoresistance of gastric cancer cells

Oncology Reports

Volumn 24, Issue 1, 2010, Pages 113-119

  Yu, Liang Liang ^a   Dai, Ning ^a   Yu, Hong Gang ^b   Sun, Lei Min ^a   Si, Jian Min ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Akt; Chemotherapy of tumor; Gastric cancer cell; NF B

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; SGC 7901; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; WORTMANNIN; ANDROSTANE DERIVATIVE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; DNA; ENZYME INHIBITOR; I KAPPA B; LEUPEPTIN; NF-KAPPAB INHIBITOR ALPHA; ONCOPROTEIN; PROTEIN BINDING;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL GROWTH; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME REPRESSION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; STOMACH CANCER; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CARCINOMA; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; METABOLISM; PATHOLOGY; PHYSIOLOGY; STOMACH NEOPLASMS; TUMOR CELL CULTURE;

ANDROSTADIENES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CELL PROLIFERATION; DNA; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS; I-KAPPA B PROTEINS; LEUPEPTINS; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; PROTEIN BINDING; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77953000927     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000835     Document Type: Article

References (36)

1. Bouali S, Chrétien AS, Ramacci C, Rouyer M, Becuwe P and Merlin JL: PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells. Oncol Rep 21: 731-735, 2009.
2. Wang YA, Johnson SK, Brown BL and Dobson PR: Differential enhancement of the anti-cancer effect of doxorubicin by Akt inhibitors on human breast cancer cells with differing genetic backgrounds. Oncol Rep 21: 437-442, 2009.
3. Bhardwaj A, Sethi G, Vadhan-Raj S, et al: Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109: 2293-2302, 2007. (Pubitemid 46425866)
4. Fan S, Meng Q, Laterra JJ and Rosen EM: Role of Src signal transduction pathways in scatter factor-mediated cellular protection. J Biol Chem 284: 7561-7577, 2009.
5. Pierau M, Engelmann S, Reinhold D, Lapp T, Schraven B and Bommhardt UH: Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation. J Immunol 183: 6124-6134, 2009.
6. Bleau AM, Hambardzumyan D, Ozawa T, et al: PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4: 226-235, 2009.
7. Yoshioka A, Miyata H, Doki Y, et al: The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis. Oncol Rep 19: 1099-1107, 2008.
8. Gangadharan C, Thoh M and Manna SK: Inhibition of constitutive activity of nuclear transcription factor kappaB sensitizes doxorubicin-resistant cells to apoptosis. J Cell Biochem 107: 203-213, 2009.
9. Ammann JU, Haag C, Kasperczyk H, Debatin KM and Fulda S: Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-kappaB inhibition. Int J Cancer 124: 1301-1311, 2009.
10. Chen R, Alvero AB, Silasi DA, et al: Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 27: 4712-4723, 2008.
11. Delgado JS, Mustafi R, Yee J, et al: Sorafenib triggers anti-proliferative and pro-apoptotic signals in human esophageal adenocarcinoma cells. Dig Dis Sci 53: 3055-3064, 2008.
12. Arlt A, Gehrz A, Müerköster S, et al: Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 22: 3243-3251, 2003. (Pubitemid 36712936)
13. Grandage VL, Gale RE, Linch DC and Khwaja A: PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia 19: 586-594, 2005.
14. Meng F, Liu L, Chin PC and D'Mello SR: Akt is a downstream target of NF-kappa B. J Biol Chem 277: 29674-29680, 2002.
15. Delhase M, Li N and Karin M: Kinase regulation in inflammatory response. Nature 406: 367-368, 2000.
16. Zabel U, Henkel T, Silva MS and Baeuerle PA: Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 12: 201-211, 1993. (Pubitemid 23042397)
17. Huang Y, Johnson KR, Norris JS and Fan W: Nuclear factor-κB/ IκB signaling pathway may contribute to the mediation of paclitaxel induced apoptosis in solid tumor cells. Cancer Res 60: 4426-4432, 2000. (Pubitemid 32103621)
18. Wong BC, Jiang X, Fan XM, et al: Suppression of RelA/ p65 nuclear translocation independent of IκBα degradation by cyclooxygenase-2 inhibitor in gastric cancer. Oncogene 22: 1189-1197, 2003. (Pubitemid 36363382)
19. Sosic D, Richardson JA, Yu K, Ornitz DM and Olson EN: Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 112: 169-180, 2003. (Pubitemid 36144107)
20. Chen YY, Wang ZX, Chang PA, et al: Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance. Cancer Sci 100: 1708-1713, 2009.
21. Sung B, Kunnumakkara AB, Sethi G, Anand P, Guha S and Aggarwal BB: Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol Cancer Ther 8: 959-970, 2009.
22. Oki E, Baba H, Tokunaga E, et al: Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int J Cancer 117: 376-380, 2005. (Pubitemid 41429560)
23. Bellacosa A, Testa JR, Staal SP and Tsichlis PN: A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254: 274-277, 1991. (Pubitemid 21917339)
24. Jones PF, Jakubowicz T, Pitossi FJ, Maurer F and Hemmings BA: Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 88: 4171-4175, 1991. (Pubitemid 21914501)
25. Fine B, Hodakoski C, Koujak S, et al: Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science 325: 1261-1265, 2009.
26. Waugh C, Sinclair L, Finlay D, Bayascas JR and Cantrell D: Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation. Mol Cell Biol 29: 5952-5962, 2009.
27. Dibble CC and Manning BD: A molecular link between AKT regulation and chemotherapeutic response. Cancer Cell 16: 178-180, 2009.
28. Weng JR, Tsai CH, Omar HA, et al: OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-kappaB pathway and stress response signaling. Carcinogenesis 30: 1702-1709, 2009.
29. Qiu J, Wang X, Guo X, Zhao C, Wu X and Zhang Y: Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines. Oncol Rep 22: 935-941, 2009.
30. Baek MK, Kim MH, Jang HJ, et al: EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells. Oncol Rep 20: 1569-1575, 2008.
31. Doger FK, Meteoglu I, Ozkara E, Erkul ZK, Okyay P and Yükselen V: Expression of NF-kappaB in Helicobacter pylori infection. Dig Dis Sci 51: 2306-2309, 2006.
32. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436, 2006.
33. Cardone MH, Roy N, Stennicke HR, et al: Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998. (Pubitemid 28524494)
34. Lee BL, Lee HS, Jung J, et al: Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res 11: 2518-2525, 2005. (Pubitemid 40569448)
35. Lawrence T, Bebien M, Liu GY, Nizet V and Karin M: IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434: 1138-1143, 2005. (Pubitemid 40663493)
36. Reddy SAG, Huang JH and Liao WSL: Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-κB activation. J Immunol 164: 1355-1363, 2000. (Pubitemid 30067249)